Panaya Earns FDA Declaration of Conformance

Share Article

Leading Pharmaceuticals Use Panaya’s Software-as-a-Service for SAP and Oracle Upgrade and Test Automation

News Image
With nearly half of the top pharmaceutical companies using Panaya, we have become an almost de-facto standard in the industry for companies that need to reduce the risk and cost of ERP changes

A leading vendor of software-as-a-service for upgrade and test automation for SAP and Oracle ERP systems, Panaya, announced today that following an independent third-party assessment, it has earned a Declaration of Conformance with FDA regulations 21 CFR Part 11 (Electronic Records and Electronic Signatures) and Guidance for Industry Part 11 (Electronic Records and Electronic Signatures).

SAP and Oracle customers who need to meet FDA compliance can continue benefiting from Panaya’s upgrade and test automation software-as-a-service, knowing that it conforms to the FDA regulations for electronic records and electronic signatures.

“With nearly half of the top pharmaceutical companies using Panaya, we have become an almost de-facto standard in the industry for companies that need to reduce the risk and cost of ERP changes,” explained Yossi Cohen, Panaya Founder & CEO. “Our conformance with FDA regulations makes it even easier for such companies to choose Panaya."

To receive a copy of Panaya’s Declaration of Conformance or 21 CFR 11 Assessment Summary please e-mail compliance(at)panayainc(dot)com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Udi Ledergor
Panaya
415-329-0200
Email >
Visit website